Leadership Overview
Boston Scientific has 10 executives leading key functions including technology, finance, information, and medical affairs.
Driven by innovation, Boston Scientific is dedicated to developing minimally invasive medical technologies that improve patient outcomes and clinical efficiency across global healthcare systems.
Driven by innovation, Boston Scientific is dedicated to developing minimally invasive medical technologies that improve patient outcomes and clinical efficiency across global healthcare systems.
Leadership Roles at Boston Scientific
Bernardo Del - Director, Finance (Country & Chief Financial Officer (Mexico)
Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, manages the financial operations and strategic fiscal planning for the Mexican market. This critical position involves overseeing all aspects of financial management, including budgeting, forecasting, and financial reporting, to ensure fiscal health and compliance within the region. Bernardo Del drives financial performance by identifying opportunities for revenue growth and cost optimization, directly supporting Boston Scientific's expansion and operational efficiency in Mexico. The Director, Finance (Country & Chief Financial Officer (Mexico) collaborates with regional leadership to align financial strategies with business objectives, ensuring robust financial controls and sustainable growth. Through diligent financial oversight, Bernardo Del contributes significantly to the company's market presence and long-term financial stability in Latin America.
Daniel Brennan - Executive Vice President & Chief Financial Officer
Daniel Brennan, the Executive Vice President & Chief Financial Officer at Boston Scientific, directs the company's global financial strategy and operations. This senior leadership position involves overseeing all financial planning, accounting, treasury, and investor relations activities to ensure fiscal strength and strategic alignment. Daniel Brennan drives financial performance by managing capital allocation, optimizing financial resources, and ensuring compliance with global financial regulations. The Executive Vice President & Chief Financial Officer plays a crucial role in guiding the company's financial health, supporting strategic investments in research and development, and enhancing shareholder value. Through expert financial stewardship, Daniel Brennan underpins Boston Scientific's ability to innovate and expand its market reach worldwide.
Bas Burk - President
Bas Burk, the President at Boston Scientific, holds broad executive responsibility for driving the company's strategic direction and operational performance. This leadership role encompasses overseeing multiple business units and functional areas to ensure the successful execution of Boston Scientific's mission to transform lives through innovative medical technologies. Bas Burk focuses on fostering a culture of excellence, promoting cross-divisional synergy, and guiding the company's growth initiatives in key global markets. The President plays a vital part in shaping the company's long-term vision, ensuring robust financial health, and maintaining strong relationships with stakeholders, including employees, customers, and investors. Through decisive leadership, Bas Burk steers Boston Scientific towards continued success and leadership in the medical device industry.
Guangqiang Jiang - Chief Technology Officer
Guangqiang Jiang, the Chief Technology Officer at Boston Scientific, directs the company's overarching technology strategy and innovation pipeline. This leadership role involves guiding research and development efforts to create next-generation medical devices that enhance patient care and procedural effectiveness. Overseeing the integration of advanced technologies, Guangqiang Jiang ensures that Boston Scientific remains at the forefront of medical device innovation. The Chief Technology Officer's focus extends to fostering a culture of technological excellence, driving the development of solutions that address unmet clinical needs across various interventional specialties. By championing cutting-edge research, Guangqiang Jiang supports the company's mission to transform lives through minimally invasive technologies, impacting global healthcare delivery and patient well-being.
Rafael Carbunaru - Chief Technology Officer, Neuromodulation
Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, spearheads technological advancements within the company's neuromodulation division. This executive directs the research, development, and implementation of innovative technologies designed to treat neurological conditions. Overseeing the engineering and product development teams, Rafael Carbunaru ensures the creation of cutting-edge devices that improve patient quality of life. The Chief Technology Officer, Neuromodulation's responsibilities include driving technological roadmaps, fostering cross-functional collaboration, and maintaining a competitive edge in the rapidly evolving field of neuromodulation. By focusing on scientific rigor and technological innovation, Rafael Carbunaru significantly contributes to Boston Scientific's leadership in developing advanced therapies for patients worldwide.
Charlene Stoessel - Chief Information Officer & Senior Vice President
Charlene Stoessel, the Chief Information Officer & Senior Vice President at Boston Scientific, leads the global information technology strategy and operations. This executive directs the development and implementation of robust IT infrastructure, systems, and digital solutions that support the company's worldwide business objectives. Overseeing cybersecurity, data management, and digital transformation initiatives, Charlene Stoessel ensures operational efficiency and data integrity across all functions. The Chief Information Officer & Senior Vice President plays a pivotal role in leveraging technology to enhance clinical efficiency, improve patient outcomes, and drive business growth. By championing digital innovation, Charlene Stoessel enables Boston Scientific to maintain its competitive advantage and adapt to the evolving technological landscape in the medical device industry.
Chan Ella - Vascular Strategy Lead Chief of Staff
Chan Ella, the Vascular Strategy Lead Chief of Staff at Boston Scientific, provides strategic support and operational leadership within the vascular division. This role involves coordinating key initiatives, facilitating cross-functional collaboration, and driving strategic planning to advance the vascular business segment. Chan Ella works closely with leadership to ensure alignment on strategic priorities, optimize operational execution, and enhance market penetration for vascular technologies. The Vascular Strategy Lead Chief of Staff focuses on translating strategic vision into actionable plans, supporting the development and commercialization of innovative solutions that improve patient care in vascular interventions. By streamlining operations and fostering strategic coherence, Chan Ella significantly contributes to Boston Scientific's leadership in the vascular market.
Brian Dunkin - Chief Medical Officer
Brian Dunkin, the Chief Medical Officer at Boston Scientific, provides critical medical and scientific leadership across the organization. This executive guides the company's clinical strategy, ensuring that product development and commercialization efforts are aligned with the highest standards of patient care and clinical evidence. Brian Dunkin oversees clinical trials, regulatory affairs, and medical affairs functions, driving the generation of robust data to support the efficacy and safety of Boston Scientific's medical devices. The Chief Medical Officer plays an essential role in translating clinical insights into product innovation and market adoption, fostering strong relationships with healthcare professionals and key opinion leaders globally. Through dedicated medical oversight, Brian Dunkin champions improved patient outcomes and advances the company's mission to transform lives.
Mingdong Zhang - Chief Medical Officer & Vice President, Medical Affairs
Mingdong Zhang, the Chief Medical Officer & Vice President, Medical Affairs at Boston Scientific, leads the company's medical affairs strategy and execution. This executive directs the medical communication, clinical education, and scientific engagement initiatives that support Boston Scientific's portfolio of medical devices. Mingdong Zhang ensures that medical information is accurately disseminated to healthcare professionals, fostering a deep understanding of product benefits and clinical applications. The Chief Medical Officer & Vice President, Medical Affairs collaborates closely with research and development teams to integrate medical insights into product design and clinical strategy. By championing evidence-based medicine and scientific exchange, Mingdong Zhang significantly enhances Boston Scientific's reputation and impact within the global healthcare community.
Scott Kreiner - Chief Medical Officer, Neuromodulation
Scott Kreiner, the Chief Medical Officer, Neuromodulation at Boston Scientific, provides specialized medical leadership for the neuromodulation division. This executive guides the clinical strategy and medical affairs activities related to the development and commercialization of therapies for neurological conditions. Scott Kreiner ensures that all neuromodulation products meet rigorous clinical standards and address critical patient needs. The Chief Medical Officer, Neuromodulation collaborates with R&D, marketing, and sales teams to translate clinical insights into effective treatment solutions. By focusing on advancing patient care through innovative neuromodulation technologies, Scott Kreiner significantly contributes to Boston Scientific's mission of improving lives and enhancing clinical outcomes in this specialized field.
Explore Leadership Teams in Manufacturing
Advita Ortho, headquartered in Gainesville, Florida, is a global medical device company dedicated to advancing patient lives through innovative orthopedic solutions. Officially launched in November 2025, the company delivers high-quality orthopedic implants and a comprehensive suite of integrated surgical technologies powered by data, artificial intelligence, and machine learning. Advita Ortho owns and distributes established product lines including the Equinoxe Shoulder, Vantage Ankle, Alteon Hip, Truliant Knee, Newton balancing technology, and GPS navigation systems, among others. The company's portfolio creates an ecosystem designed to enhance surgical decision-making in the operating room while driving efficiency for healthcare systems. Led by industry veterans and backed by investment firms including Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management, Advita Ortho positions itself as a trusted partner to orthopedic surgeons worldwide, providing tools and technologies designed to improve patient outcomes and quality of life.
Company Leadership
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
CB
Founded in 1945, Micro Stamping is a full-service contract manufacturing company that specializes in medical devices such as, titanium and stainless steel ligation clips and implant devices. Micro Stamping is located in New Jersey.
Company Leadership LW
DT
ED
DB
AxoGen is a medical device manufacturing company founded in 2002 that specializes in developing and producing surgical solutions for peripheral nerve injuries. The company offers a comprehensive portfolio of products including nerve grafts, connectors, and protectors designed to facilitate nerve repair and regeneration. AxoGen's innovative solutions include the Avance Nerve Graft for bridging severed nerves, AxoGuard Nerve Connector for tensionless nerve repair, and AxoGuard Nerve Protector for protecting injured peripheral nerves. Additionally, the company provides diagnostic and measurement tools such as the AcroVal neurosensory testing system and AxoTouch discriminator. AxoGen distributes its products to hospitals, surgery centers, and military medical facilities across North America, Europe, and other international markets, serving the needs of surgeons and patients in peripheral nerve repair procedures.
Company Leadership
LH
Frequently Asked Questions Regarding Boston Scientific Top Executives and Leadership Team
Unlock more people and company data
